Top 5 Stocks to Double in 2022
Reach Your Investing Goals with These 5 Stocks… Sign Up for your Free Report: Top 5 Stocks to Double in 2022.
>>>
pixel
Anna Mowry net worth and biography

Anna Mowry Biography and Net Worth

Anna is an experienced finance and business leader who joins Nautilus from Igneous where she served as VP of Finance and Operations with responsibility for finance, accounting, people, legal, and operations. Previously, Anna held a variety of roles at companies including Amazon Web Services and Isilon Systems, where she ultimately led the finance and sales operations organization. Anna has a BS in Biochemistry from Western Washington University and started her career at the Fred Hutchinson Cancer Research Institute. She earned her MBA from the University of Washington, leading her into a variety of finance and business roles of escalating responsibility.

What is Anna Mowry's net worth?

The estimated net worth of Anna Mowry is at least $120,310.00 as of August 19th, 2022. Ms. Mowry owns 56,750 shares of Nautilus Biotechnology stock worth more than $120,310 as of October 3rd. This net worth evaluation does not reflect any other investments that Ms. Mowry may own. Learn More about Anna Mowry's net worth.

How do I contact Anna Mowry?

The corporate mailing address for Ms. Mowry and other Nautilus Biotechnology executives is 51 ASTOR PLACE 10TH FLOOR, NEW YORK NY, 10003. Nautilus Biotechnology can also be reached via phone at 206-333-2001 and via email at [email protected] Learn More on Anna Mowry's contact information.

Has Anna Mowry been buying or selling shares of Nautilus Biotechnology?

Anna Mowry has not been actively trading shares of Nautilus Biotechnology during the last ninety days. Most recently, on Friday, August 19th, Anna Mowry bought 17,500 shares of Nautilus Biotechnology stock. The stock was acquired at an average cost of $2.30 per share, with a total value of $40,250.00. Following the completion of the transaction, the chief financial officer now directly owns 56,750 shares of the company's stock, valued at $130,525. Learn More on Anna Mowry's trading history.

Who are Nautilus Biotechnology's active insiders?

Nautilus Biotechnology's insider roster includes Matthew Mcilwain (Director), Anna Mowry (CFO), Matthew Murphy (General Counsel), Sujal Patel (CEO), and Matthew Posard (Director). Learn More on Nautilus Biotechnology's active insiders.

Are insiders buying or selling shares of Nautilus Biotechnology?

In the last year, Nautilus Biotechnology insiders bought shares 15 times. They purchased a total of 744,978 shares worth more than $3,234,519.62. The most recent insider tranaction occured on September, 26th when VP Subramanian Sankar bought 10,000 shares worth more than $20,200.00. Insiders at Nautilus Biotechnology own 41.3 % of the company. Learn More about insider trades at Nautilus Biotechnology.

Information on this page was last updated on 9/26/2022.

Anna Mowry Insider Trading History at Nautilus Biotechnology

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/19/2022Buy17,500$2.30$40,250.0056,750View SEC Filing Icon  
6/27/2022Buy5,500$2.75$15,125.0039,250View SEC Filing Icon  
8/12/2021Buy17,500$7.71$134,925.00View SEC Filing Icon  
See Full Table

Anna Mowry Buying and Selling Activity at Nautilus Biotechnology

This chart shows Anna Mowry's buying and selling at Nautilus Biotechnology by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Nautilus Biotechnology Company Overview

Nautilus Biotechnology logo
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
Read More

Today's Range

Now: $2.15
Low: $2.09
High: $2.18

50 Day Range

MA: $2.41
Low: $1.96
High: $2.94

2 Week Range

Now: $2.15
Low: $1.86
High: $6.33

Volume

75,225 shs

Average Volume

303,000 shs

Market Capitalization

$268.03 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.81